Dr. Ryosuke Misawa, MD
Transplant Surgery (Transplant Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 41
Licensed in Connecticut since 2025, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Transplant Surgery Physician primary
CT license 83631 (first issued 2025; active) · NY license 308337 -
Surgery Physician
NY license 308337
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Yale-New Haven Hospital New Haven, CT
- Westchester Medical Center Valhalla, NY
Medical groups
- Yale University (2,645 clinicians)
- Westchester Medical Center Advanced Physician Services PC (897 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 41
- Services billed
- 218
- Patients’ average age
- 62
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 87 | 26 |
| New patient office or other outpatient visit, 60-74 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 9 companies reported 12 payments worth $767 in total to this clinician.
| Dilon Technologies, Inc. | $219 |
|---|---|
| Becton, Dickinson and Company | $171 |
| Ethicon US, LLC | $148 |
| W. L. Gore & Associates, Inc. | $68.44 |
| Organox LTD | $64.45 |
| Ipsen Biopharmaceuticals, Inc | $32.39 |
| Veloxis Pharmaceuticals, Inc. | $30.63 |
| Intercept Pharmaceuticals, Inc. | $17.64 |
| Food and Beverage | $767 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.